The Senate voted 52-47 on Friday to confirm Representative Tom Price as the top U.S. healthcare official, putting a determined opponent of Obamacare in position to help President Donald Trump dismantle the healthcare law. Price, in his new job, will have authority to rewrite rules implementing the 2010 Affordable Care Act.
CNN reported on Sunday that Price bought between $1,001 and $15,000 worth of shares last March in Zimmer Biomet Holdings Inc, a medical device manufacturer. Days later, he introduced legislation to the House of Representatives that would have delayed a regulation that could have ultimately damaged the company.
Jeff Danziger’s award-winning drawings, syndicated by the Washington Post Writers Group, are published by more than 600 newspapers and websites. He has been a cartoonist for the Rutland Herald, the New York Daily News and the Christian Science Monitor; his work has appeared in newspapers from the Wall Street Journal to Le Monde and Izvestia. He […]